Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Pharmacology
|
September 29, 2022
Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc<sup>-</sup> to deplete GSH
Xianling Ning, Hailong Qi, Yuyao Yuan, et al.
European Journal of Medicinal Chemistry
|
March 18, 2019
Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors
Bin Liu, Xia Yuan, Bo Xu, et al.
Organic Letters
|
May 15, 2020
Ruthenium-Catalyzed Highly Enantioselective Synthesis of <i>cis</i>-3-Quinuclidinols via DKR Asymmetric Transfer Hydrogenation
Zhonghua Luo, Zhongqing Wang, Guodong Sun, et al.
Bioorganic & Medicinal Chemistry
|
August 10, 2019
Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors
Zheng Zhai, Ridong Li, Xinyu Bai, et al.
European Journal of Medicinal Chemistry
|
February 28, 2018
Discovery and optimization of 2-thio-5-amino substituted benzoquinones as potent anticancer agents
Yuqiong Zhao, Yihuan Lu, Ridong Li, et al.
European Journal of Medicinal Chemistry
|
July 9, 2017
Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase
Xianling Ning, Hailong Qi, Ridong Li, et al.
Bioorganic & Medicinal Chemistry
|
June 22, 2017
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors
Liqiang Han, Yanzhao Wen, Ridong Li, et al.
European Journal of Medicinal Chemistry
|
May 27, 2019
Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities
Yue Su, Ridong Li, Xianling Ning, et al.
European Journal of Medicinal Chemistry
|
June 27, 2025
Molecular hybridization-driven FAK inhibitors: N-2,4-diarylaminopyrimidine-3-sulfamoyl-benzamide derivatives with improved antitumor potency
Lidong Gong, Zichao Liang, Xianling Ning, et al.
Bioorganic & Medicinal Chemistry
|
June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds
Yu Zhang, Bin Liu, Xingyu Wu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Pharmacology
|
September 29, 2022
Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc<sup>-</sup> to deplete GSH
Xianling Ning, Hailong Qi, Yuyao Yuan, et al.
European Journal of Medicinal Chemistry
|
March 18, 2019
Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors
Bin Liu, Xia Yuan, Bo Xu, et al.
Organic Letters
|
May 15, 2020
Ruthenium-Catalyzed Highly Enantioselective Synthesis of <i>cis</i>-3-Quinuclidinols via DKR Asymmetric Transfer Hydrogenation
Zhonghua Luo, Zhongqing Wang, Guodong Sun, et al.
Bioorganic & Medicinal Chemistry
|
August 10, 2019
Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors
Zheng Zhai, Ridong Li, Xinyu Bai, et al.
European Journal of Medicinal Chemistry
|
February 28, 2018
Discovery and optimization of 2-thio-5-amino substituted benzoquinones as potent anticancer agents
Yuqiong Zhao, Yihuan Lu, Ridong Li, et al.
European Journal of Medicinal Chemistry
|
July 9, 2017
Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase
Xianling Ning, Hailong Qi, Ridong Li, et al.
Bioorganic & Medicinal Chemistry
|
June 22, 2017
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors
Liqiang Han, Yanzhao Wen, Ridong Li, et al.
European Journal of Medicinal Chemistry
|
May 27, 2019
Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities
Yue Su, Ridong Li, Xianling Ning, et al.
European Journal of Medicinal Chemistry
|
June 27, 2025
Molecular hybridization-driven FAK inhibitors: N-2,4-diarylaminopyrimidine-3-sulfamoyl-benzamide derivatives with improved antitumor potency
Lidong Gong, Zichao Liang, Xianling Ning, et al.
Bioorganic & Medicinal Chemistry
|
June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds
Yu Zhang, Bin Liu, Xingyu Wu, et al.
Page
of 4